Press Releases
-
Dec17
Cancer Genetics Terminates Proposed Merger with NovellusDx
RUTHERFORD, N.J., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling
-
Nov19
Cancer Genetics Reports Third Quarter 2018 Financial Results and Provides Strategic Business Updates
RUTHERFORD, N.J., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling
-
Nov14
Cancer Genetics Appoints Glenn Miles as Chief Financial Officer
RUTHERFORD, N.J., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision
-
Oct18
Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin® Test in China
RUTHERFORD, N.J., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling
-
Oct16
Cancer Genetics Issues Letter to Shareholders
RUTHERFORD, N.J., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision
-
Oct8
Cancer Genetics and Cellaria Partner on Precision Medicine Tools
Collaboration focused on developing pharmacology models to support biopharma R&D RUTHERFORD, N.J., Oct. 08, 2018
-
Sep25
Cancer Genetics Enters Supply Agreement with Agilent Technologies
Probes for CGI’s FISH-based HPV-Associated Cancer Test (FHACT®) test to be manufactured by Agilent RUTHERFORD,
-
Sep20
Cancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical Trials
RUTHERFORD, N.J., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling
-
Sep18
Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge
Transaction to Create a Leader in Precision Oncology RUTHERFORD, N.J. and JERUSALEM, Sept. 18, 2018 (GLOBE
-
Aug14
Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates
Conference call at 8:30 a.m. ET, Tuesday, August 14, 2018 RUTHERFORD, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) --
